Connection

KEITH WEBSTER to Genetic Therapy

This is a "connection" page, showing publications KEITH WEBSTER has written about Genetic Therapy.
Connection Strength

0.866
  1. Vascular Regeneration in Ischemic Hindlimb by Adeno-Associated Virus Expressing Conditionally Silenced Vascular Endothelial Growth Factor. J Am Heart Assoc. 2016 05 26; 5(6).
    View in: PubMed
    Score: 0.353
  2. Angiogenesis is confined to the transient period of VEGF expression that follows adenoviral gene delivery to ischemic muscle. Gene Ther. 2005 May; 12(9):762-71.
    View in: PubMed
    Score: 0.164
  3. Suppression of matrigel-induced choroidal neovascularization by AAV delivery of a novel anti-Scg3 antibody. Gene Ther. 2024 Nov; 31(11-12):587-593.
    View in: PubMed
    Score: 0.157
  4. Gene and cell therapy for heart disease. IUBMB Life. 2002 Aug; 54(2):59-66.
    View in: PubMed
    Score: 0.136
  5. Therapeutic angiogenesis: a case for targeted, regulated gene delivery. Crit Rev Eukaryot Gene Expr. 2000; 10(2):113-25.
    View in: PubMed
    Score: 0.028
  6. Osteopontin Promotes Left Ventricular Diastolic Dysfunction Through a Mitochondrial Pathway. J Am Coll Cardiol. 2019 06 04; 73(21):2705-2718.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.